It receives inputs from the limbic system and the basal ganglia and sends outputs to midbrain areas that are involved in the release of dopamine (the substantia nigra pars compacta and ventral ...

warns that this therapy might cause neuronal death in the substantia nigra (SN) and could predispose individuals to hyperkinetic movement disorders and seizures. Hatzipetros et al. conclude that ...

describing a study in which researchers recorded dopamine and serotonin levels in the substantia nigra pars reticulata of patients with Parkinson’s disease undergoing DBS surgery. Disclaimer ...